Canada’s Largest Cannabis Producer Brings Down CBD Oil Costs by 96.34%
TORONTO--(BUSINESS WIRE)--Dec 27, 2018--Flying under the radar for the past few months, InstaDose Pharma is ready to hit the market with 2 million liters of CBD oil in 2019. InstaDose Pharma has over 200,000 farmers harvesting cannabis out of the Democratic Republic of the Congo on over 100,000 hectares of land. The main production facility is GMP certified and pharmaceutically accredited with EU Pharmacopeia standards.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181227005225/en/
CEO of Instadose Pharma Grant Sanders meeting with the Vice Minister of agriculture of the Democratic Republic of the Congo (Photo: Business Wire)
“The cannabis companies of Canada need to understand that just because you are the biggest goldfish in the pond doesn’t mean you shouldn’t be concerned about the whales in the ocean. Everything in the Canadian cannabis industry is based off the cost being $2800 per litre for CBD oil. While international forces outside the Canadian bubble are able to produce 99.7% purity level at $102.50 USD per litre.” said Grant F Sanders, CEO, Instadose Pharma Corp., “We’ve kept our operations in the shadows due to concerns about the reaction of this news with licensed producers and the public investment sector. But now that our first crops are about to hit the markets in a few months, I think it’s about time the fish learned about the whale.”
To date, Grant has spent over $76 Million USD on building the current operation and is already in motion to expand production land to 250,000 hectares after the first 90,000 liters hit the Canadian market. IDP is currently in discussions with major pharmaceutical companies to assist with the release of the first batch imported into Canada.
Currently, the largest licensed producer of cannabis in Canada, Canopy, has approximately 40 hectares of production land. At 400 hectares, IDP has 10 times that amount of that in Colombia alone. According to Grant Sanders, Colombia was just not enough for them to be able to expand to their maximum potential. “We quickly realized that growing there was not the smartest option and the production capacity and price that we could achieve in the DRC was 99% more beneficial, to both us and the end user,” said Sanders. “What’s about to happen to the market isn’t a result of what we’re doing, it’s the result of what they’re not. You can’t blame Usain Bolt for being the fastest runner in the world just because you’re too slow”.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181227005225/en/
CONTACT: Marco Gobbatto
Media Manager, Liquid Communications
(416) 732 6773
KEYWORD: NORTH AMERICA CANADA
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Liquid Communications
Copyright Business Wire 2018.
PUB: 12/27/2018 09:38 AM/DISC: 12/27/2018 09:38 AM